93 T13 (Fexofenadine and Pseudoephedrine Extended Release 60 mg / 120 mg)

Pill imprint 93 T13 has been identified as Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 60 mg / 120 mg.

Fexofenadine/pseudoephedrine is used in the treatment of hay fever and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. Fexofenadine/pseudoephedrine 60 mg / 120 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for 93 T13

Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 60 mg / 120 mg 93 T13
Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release 60 mg / 120 mg 93 T13
Fexofenadine hydrochloride and pseudoephedrine hydrochloride extended release
Imprint:
93 T13
Strength:
60 mg / 120 mg
Color:
Tan & White
Size:
19.00 mm
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Upper respiratory combinations
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Teva Pharmaceuticals USA
National Drug Code (NDC):
00093-1130
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-6087 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)